Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.64 is 239% above its 4-year average of 0.78, near the low end of its 4-year range (0.00–12.48).
As of the fiscal period ended Tuesday, June 30, 2026. 38.42% above its 12-month average of 1.91.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.64.
CURRENT RATIO
2.64
CURRENT RATIO AVG TTM
1.91
CURRENT RATIO AVG 3Y
1.39
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+38.42%
CURRENT VS 3Y AVG
+89.87%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.57
median of 739 covered companies
CURRENT VS SECTOR MEDIAN
-25.95%
vs the sector median at left
FibroBiologics, Inc. Common Stock
Market Cap
$2.52M
Current Ratio
2.64
TTM Avg
1.91
3Y Avg
1.39
5Y Avg
N/A
Market Cap
$2.51M
Current Ratio
1.44
TTM Avg
1.74
3Y Avg
3.93
5Y Avg
2.64
Market Cap
$2.32M
Current Ratio
12.91
TTM Avg
22.35
3Y Avg
19.50
5Y Avg
14.70
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| FibroBiologics, Inc. Common Stock (FBLG) | $2.52M | 2.64 | 1.91 | 1.39 | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.51M | 1.44 | 1.74 | 3.93 | 2.64 |
| Jaguar Health, Inc. (JAGX)vs › | $2.56M | 0.69 | 1.06 | 1.22 | 1.34 |
| Nuwellis, Inc. (NUWE)vs › | $2.62M | 1.97 | 2.58 | 3.16 | 4.38 |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.43M | 0.94 | 1.19 | 3.93 | 6.93 |
| iSpecimen Inc. (ISPC)vs › | $2.63M | 0.82 | 0.87 | 1.93 | 3.50 |
| Onconetix, Inc. (ONCO)vs › | $2.38M | 2.21 | 0.36 | 1.94 | 12.76 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | 12.91 | 22.35 | 19.50 | 14.70 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.25M | 1.54 | 2.65 | 3.41 | 4.73 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.00M | 1.41 | 2.85 | 1.58 | 2.33 |
Current Ratio
2.64
Quick Ratio
2.64
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.64 |
| 2026-03-31 | 1.59 |
| 2025-12-31 | 3.61 |
| 2025-09-30 | 0.78 |
| 2025-06-30 | 0.93 |
| 2025-03-31 | 1.14 |
| 2024-12-31 | 1.12 |
| 2024-09-30 | 1.23 |
| 2024-06-30 | 0.64 |
| 2024-03-31 | 0.64 |
| 2023-12-31 | 1.00 |
| 2023-09-30 | 8.31 |
| 2023-06-30 | 12.48 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.00 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
